Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
The METHRO trials
Ali Hamaad, Muzahir Tayebjee,
Gregory Lip
Birmingham Medical School
Cardiovascular Sciences
Research output
:
Contribution to journal
›
Review article
8
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The METHRO trials'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Warfarin
100%
Low Molecular Weight Heparin
100%
Melagatran
66%
Orthopedic Surgery
66%
Ximelagatran
66%
Subcutaneous Injection
33%
Anticoagulation
33%
Venous Thromboembolism
33%
Oral Anticoagulation
33%
Dosage Adjustment
33%
Therapeutic Drug Monitoring
33%
Anticoagulants
33%
Prophylactic Strategy
33%
Hospital Inpatients
33%
Fatal Complication
33%
Thrombin Inhibition
33%
Venous Thromboembolism Prophylaxis
33%
Pharmacology, Toxicology and Pharmaceutical Science
Warfarin
100%
Low Molecular Weight Heparin
100%
Melagatran
66%
Ximelagatran
66%
Subcutaneous Injection
33%
Venous Thromboembolism
33%
Therapeutic Drug Monitoring
33%
Anticoagulant Agent
33%
Thrombin
33%